Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological Analysis of a CCHFV mRNA Vaccine Candidate in Mouse Models
Authors
Keywords
-
Journal
Vaccines
Volume 7, Issue 3, Pages 115
Publisher
MDPI AG
Online
2019-09-17
DOI
10.3390/vaccines7030115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus
- (2019) Touraj Aligholipour Farzani et al. Viruses-Basel
- Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
- (2019) E. Criscuolo et al. Journal of Immunology Research
- Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models
- (2019) Touraj Aligholipour Farzani et al. Viruses-Basel
- Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease
- (2019) Garrison et al. Viruses-Basel
- Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
- (2019) Sergio E. Rodriguez et al. Scientific Reports
- A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
- (2019) Liu Vaccines
- mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
- (2018) Yuhua Wang et al. MOLECULAR THERAPY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge
- (2018) Marko Zivcec et al. PLoS Neglected Tropical Diseases
- New Vaccine Technologies to Combat Outbreak Situations
- (2018) Susanne Rauch et al. Frontiers in Immunology
- Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection
- (2018) Lorna Leal et al. AIDS
- DNA Vaccines—How Far From Clinical Use?
- (2018) Dominika Hobernik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection
- (2017) Jessica R Spengler et al. JOURNAL OF INFECTIOUS DISEASES
- Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
- (2017) Darin K. Edwards et al. Journal of Translational Medicine
- Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice
- (2017) Jorma Hinkula et al. JOURNAL OF VIROLOGY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Development of vaccines against Crimean-Congo haemorrhagic fever virus
- (2017) Stuart D. Dowall et al. VACCINE
- A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models
- (2017) Aura R. Garrison et al. PLoS Neglected Tropical Diseases
- Cancer Vaccines
- (2016) Shamayel Mohammed et al. ADVANCES IN ANATOMIC PATHOLOGY
- Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)
- (2016) Alberto C. Guardo et al. AIDS
- Materials for non-viral intracellular delivery of messenger RNA therapeutics
- (2016) Kevin J. Kauffman et al. JOURNAL OF CONTROLLED RELEASE
- Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
- (2015) Hyewon Youn et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice
- (2015) Jeroen Kortekaas et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
- (2015) SD Dowall et al. Human Vaccines & Immunotherapeutics
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Crystal Structure of Vaccinia Virus mRNA Capping Enzyme Provides Insights into the Mechanism and Evolution of the Capping Apparatus
- (2014) Otto J.P. Kyrieleis et al. STRUCTURE
- Crimean-Congo Hemorrhagic Fever Virus Entry into Host Cells Occurs through the Multivesicular Body and Requires ESCRT Regulators
- (2014) Olena Shtanko et al. PLoS Pathogens
- Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity
- (2013) Dennis A. Bente et al. ANTIVIRAL RESEARCH
- Pathogenesis of Crimean-Congo Hemorrhagic Fever
- (2013) Esragül Akıncı et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- Mice Orally Immunized with a Transgenic Plant Expressing the Glycoprotein of Crimean-Congo Hemorrhagic Fever Virus
- (2011) S. M. Ghiasi et al. Clinical and Vaccine Immunology
- Bacterial expression of Crimean-Congo hemorrhagic fever virus nucleoprotein and its evaluation as a diagnostic reagent in an indirect ELISA
- (2011) Rudo R. Samudzi et al. JOURNAL OF VIROLOGICAL METHODS
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo
- (2010) A N Kuhn et al. GENE THERAPY
- Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice
- (2010) S. Bereczky et al. JOURNAL OF GENERAL VIROLOGY
- Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model
- (2010) D. A. Bente et al. JOURNAL OF VIROLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started